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Abstract
Background: In the Netherlands, incidence of physician’s consultations and hospitalizations for varicella is low
compared to other countries. Better knowledge about the severity of varicella among Dutch hospitalized patients is
needed. Therefore, a medical record research was conducted among hospitalized patients with diagnosis varicella.
Methods: Hospital admissions due to varicella in 2003-2006 were obtained from the National Medical Register.
Retrospectively, additional data were retrieved from the medical record of patients hospitalized with varicella in 23
Dutch hospitals using a standardized form. Analyses were performed using descriptive statistics.
Results: The study population (N = 296) was representative for all varicella admissions in the Netherlands (N =
1,658) regarding age, sex, duration of admission and type of diagnosis. Complications were recorded in 76% of the
patients (37% had at least one relatively severe complication). Bacterial super infections of skin lesions (28%),
(imminent) dehydration (19%), febrile convulsions (7%), pneumonia (7%) and gastroenteritis (7%) were most
frequently reported. No varicella-related death occurred within the study population and 3% of the patients had
serious rest symptoms.
Conclusions: It is not likely that the severity of varicella among hospitalized patients in the Netherlands differs
from other countries. A considerable part of the varicella complications among hospitalized patients was rather
moderate and can be treated effectively, although in a third of the hospitalized cases with complications, severe
complications occurred. These data are relevant in the decision-making process regarding whether or not to
introduce routine varicella vaccination in the Netherlands.
Background
The varicella zoster virus (VZV) causes varicella (pri-
mary infection) as well as herpes zoster (reactivation of
latent VZV in sensory nerve ganglia). Childhood vari-
cella usually results in mild to moderate illness but ser-
ious complications like central nervous system
involvement, pneumonia, secondary invasive bacterial
infections and death may occur [1]. Since a life attenu-
ated vaccine to prevent varicella has become available,
many countries consider including it in their National
Immunization Program. The United States was the first
country that introduced universal childhood varicella
vaccination. Their vaccination program started in 1995
(vaccine coverage among children aged 19 to 35 months
increased nationally from 27% in 1997 to 89% in 2006)
and has reduced overall disease incidence by 57% to
90%, hospitalizations by 75% to 88%, deaths by >74%,
and direct inpatient and outpatient medical expenditures
by 74% [2]. So far, in Europe varicella is listed as routine
childhood vaccination in Germany and Greece. In some
other European countries like Austria, Belgium, Cyprus,
France, Italy, Poland, Spain, Sweden and Switzerland,
routine childhood vaccination is only offered in some
regions, only in the private sector or only to high risk
groups and/or susceptible adolescents [3,4].
In the Netherlands [5], the number of varicella related
consultations of a general practitioner (GP), hospital
admissions and/or deaths per 100,000 inhabitants is low
compared with other countries (pre-vaccine area), such
as the United States [2], England and Wales [6-8] and
Germany [9]. In England and Wales, where the health
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there were 507 GP-consults in the period 2001-2007 [6],
5.8 hospital admissions (based on data for England only)
in 2000/2001-2008/2009 [7] and 0.038 deaths in 2000-
2008 [8] per 100,000 inhabitants annually, which is
roughly twice as much as the 238 GP-consults, 1.6 hos-
pital admissions and 0.018 deaths per 100,000 inhabi-
tants in the Netherlands in the period 2000-2008. It is
not clear to what extent these differences can be
ascribed to regional differences in the epidemiology of
VZV, considering the fact that the mean age of infection
in the Netherlands was lower than in England and
Wales according to seroprevalence studies [10]. Other
reasons might be differences in national surveillance sys-
tems, the health care system or health care seeking
behavior. If these differences could be attributed to dif-
ferences in the health care system or health care seeking
behavior, which is in general more conservative in the
Netherlands, there would be a possibility that Dutch
hospitalizations due to varicella concern more severe
cases than in other countries. Therefore, a medical
record research was conducted among hospitalized
patients with diagnosis varicella. This article presents
the results of this study.
Methods
Data on hospital admissions due to main and/or side
diagnosis varicella (ICD-9 code 052) in the period 2003-
2006 were obtained from the National Medical Register
from research institute Prismant [11]. Clinical admis-
sions were included only (admissions for one day or less
were excluded). To get more detailed insight into the
severity and complications of varicella among hospita-
lized patients, a medical record research was conducted.
An acknowledged Medical Ethical Committee of the
University Medical Centre Utrecht approved of the
study that was in accordance with the European state-
ments for good clinical practice, which includes the pro-
visions of the Declarationo fH e l s i n k io f1 9 8 9 .W e
invited 23 out of 91 Dutch hospitals (situation Novem-
ber 2009), including one of the eight academic hospitals,
to participate in this study; five of these hospitals had
more than 750 hospital beds in 2008. All the hospitals
consented in participation and patients were sent an
information letter asking permission to include their
personal medical record data in the study. Patients that
could not be reached because they had moved or died,
patients that did not give (active) permission and
patients whose medical record could not be traced were
excluded from the study. For the remaining patients,
trained and authorized medical students collected addi-
tional information on comorbidity, primary reason of
admission, complications and rest symptoms of varicella
out of the medical record using a standardized form,
under supervision of a research physician. Afterwards,
all complications were divided in relatively moderate or
relatively severe complications by a medical doctor. For
all deaths, including deceased patients that could not be
included in the full research, additional information was
collected on the cause of death and the time interval
between the admission due to varicella and death. Vari-
cella-related death was defined as death within one
month after varicella related hospital admission, unless
another cause of death than varicella was appointed.
Statistical analysis
Differences between groups of patients were tested (two-
tailed) by using Fisher’s exact test (sex, type of hospital,
type of diagnosis, having a complication), Pearsons c
2
test (ICD-9 code), Median Test (median age, median
duration of admission) or a t-test (number of complica-
tions). For all tests, a p-value of <0.05 was considered to
be statistically significant.
Results
Patient characteristics
In the 23 hospitals that consented in participation, 359
admissions with main and/or side diagnosis varicella
were registered in the National Medical Register in the
period 2003-2006. This covered 21.7% of all the national
admissions with main and/or side diagnosis varicella in
the Netherlands in this period. The medical record
research could be conducted for 301 admissions (83.8%,
see Figure 1); this concerned 296 individual patients
(some patients were registered more than once). There
was no significant difference in median age, sex, median
duration of admission, type of diagnoses (main or side)
and ICD-9 codes between the study population and all
Dutch hospitalized patients in the National Medical
Register in 2003-2006 (Table 1). When comparing the
type of hospital, the proportion admitted to an academic
hospital was lower for the study population (5.1%) com-
pared to the total group of hospitalized patients (11.2%).
The study showed that 114 of 296 patients (39%) had
an underlying chronic condition that is known from the
literature to increase the chance of getting severe vari-
cella or complications due to varicella. Most frequently
reported pre existent conditions were lung disorders,
skin disorders (mainly eczema or constitutional eczema),
malignancy/leukemia, premature birth and immunosup-
pressive therapy (Table 2). Among ‘other chronic condi-
tion’ various conditions were mentioned, such as
epilepsy, Down syndrome and a history of febrile con-
vulsions. Patients with an underlying chronic condition
were somewhat older than patients without such a con-
dition (median age 2 versus 1 years, p = 0.005) and had
a longer duration of admission (median duration 4.1
versus 2.9 days, p = 0.005). There were no significant
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(71% versus 78%, p = 0.164) and mean number of com-
plications (1.0 versus 1.1, p = 0.446) between hospita-
lized patients with and without an underlying chronic
condition.
Disease course and outcome
For 225 patients (76%) one or more varicella-related
complications were reported in the medical record (72%
among 0 year olds, 86% among 1-4 year olds and 58%
among patients aged 5 year or older). Within the group
of patients with complication(s), 37% had an underlying
pre existent condition (30% among 0 year olds, 39%
among 1-4 year olds and 44% among patients aged 5 year
or older). Of all 322 complications mentioned, 95 (30%)
were considered to be relatively severe complications (see
Table 3 for the division in relatively moderate and severe
complications). Of the 225 patients with a complication,
83 (37%) had at least one relatively severe complication.
Most frequently reported complications were bacterial
super infections of skin lesions (28%), (imminent) dehy-
dration (19%), febrile convulsion (7%), pneumonia (7%)
and gastroenteritis (7%) (Table 3). Based on the median
duration of admission, the five most frequently reported
complications can be ordered as follows: pneumonia (4.7
days), gastroenteritis (4.6 days), bacterial super infections
of skin lesions (3.7 days), (imminent) dehydration (2.8
days) and febrile convulsion (1.6 days).
For 36 patients (12%) rest symptoms were reported at
discharge. In 10 of 296 patients (3%) this concerned ser-
ious rest symptoms like residual ataxia or coordination
disorder (N = 8) or cerebral nerve paralysis (N = 2). In
another 14 patients (5%) mild rest symptoms were
reported, for example bad healing lesions (N = 10) or
scars (N = 4). There were no deaths considered to be
varicella related, although for one deceased person that
could not be included in the study we could not totally
exclude the possibility.
Comparison between National Medical Register and
medical record research
The attribution to main or side diagnosis in the
National Medical Register corresponded to the medical
record for 71% of the patients (Table 4). For 3% of the
patients varicella was found not to be the primary rea-
son for admission while this concerned a main diagno-
sis according to the National Medical Register. For
26% of the patients varicella was retrospectively con-
sidered to be the primary cause of admission while it
was only registered as side diagnosis in the National
Medical Register. In these 77 cases, the main diagnosis
as registered in the National Medical Register often
seemed a complication related to varicella (N = 66) or
sometimes a chronic condition associated with a
higher risk on a severe course of varicella (N = 5), like
for instance leukemia. The most frequently mentioned
Admissions in 23 
participating hospitals 
N=359 
Included
admissions*
N=301 (83.8%) 
Excluded 
admissions 
N=58 (16.2%) 
No mention 
varicella in MR***
N=6 (1.7%) 
Not enough data to trace 
MR/MR not available 
N=13 (3.6%) 
Patient 
deceased**
N=8 (2.2%) 
Patient 
moved**
N=5 (1.4%) 
No permission 
patient 
N=26 (7.2%) 
All admissions with varicella 
in the Netherlands, 2003-2006 
N=1,658 
Admissions in  
other hospitals 
N=1,299 
Figure 1 Flow chart of in- and excluded admissions in the medical record research.M R=m e d i c a lr e c o r d .*T he included admissions
concerned 296 individual patients (some patients were registered more than once) ** Not included because it was not possible to inform these
patients (or their relatives) *** Included at first but excluded during the study because there was no mention in MR of a varicella episode (or
only mention of a suspicion that was withdrawn after further investigation).
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lesions (26%), febrile convulsion (17%) and (imminent)
dehydration (12%).
Moreover, almost half (45%) of the varicella complica-
tions as retrieved from the medical record was not regis-
tered as such in the National Medical Register. A
detailed comparison between the medical record
research and the National Medical Register regarding
varicella complications is presented in Table 5. For
example, only 50 of the 82 (61%) bacterial super infec-
tions of skin lesions were coded in the National Medical
Register. More important, a number of serious compli-
cations such as cerebellitis/ataxia, meningitis/encephali-
tis and sepsis were only partially registered in the
National Medical Register. Of note is that the specific
ICD-codes for postvaricella encephalitis and varicella
(haemorrhagic) pneumonitis were not used in the
National Medical Register for all patients who suffered
from meningitis/encephalitis or pneumonia due to vari-
cella according to the medical record.
Discussion
The medical record research showed that varicella com-
plications occurred in the majority (76%) of hospitalized
patients; 37% of these patients had at least one relatively
severe complication. The most frequently mentioned
complication that came forward, bacterial super infec-
tions of skin lesions, usually can be treated effectively by
antibiotics. (Imminent) dehydration, the second most
frequently mentioned complication, can normally be
treated effectively by administering a rehydration solu-
tion. As expected due to the small study size, we did
not find some unusual complications of varicella known
from the literature such as Reye’s syndrome, toxic shock
syndrome, neonatal varicella and proliferative glomeru-
lonephritis. Remarkably, there were no differences in the
occurrence of complications between hospitalized
patients with and patients without an underlying
chronic condition. In 3% of the patients in this study
serious rest symptoms were reported. Based on the
cause of death and/or time between admission and
Table 1 Background characteristics of study population medical record research versus all hospitalized patients with
main or side diagnosis varicella in 2003-2006
Study population All patients 2003-2006
N%N % p-value
Age 0 year 94 31.8% 492 29.7%
1-4 year 145 49.0% 760 45.8%
≥5 year 57 19.3% 406 24.5%
Median 1 years 2 years p = 0.103
Sex Male 179 60.5% 931 56.2% p = 0.181
Female 117 39.5% 727 43.8%
Duration of admission <1 day 45 15.3% 239 14.4%
1-4 days 164 55.6% 875 52.8%
≥5 days 86 29.2% 543 32.8%
Median 3.6 days 3.3 days p = 0.658
Type of hospital Academic 15 5.1% 185 11.2% p = 0.001
Other 281 94.9% 1473 88.8%
Type of diagnosis Main 190 64.2% 1100 66.3% p = 0.465
Side 106 35.8% 558 33.7%
ICD-9 code* 052.0 2 1.1% 21 1.9% p = 0.436
main diagnosis 052.1 11 5.8% 82 7.5%
052.7 39 20.5% 261 23.7%
052.8 16 8.4% 66 6.0%
052.9 122 64.2% 670 60.9%
ICD-9 code* 052.0 0 0.0% 1 0.2% p = 0.489
side diagnosis 052.1 0 0.0% 7 1.3%
052.7 12 11.3% 72 12.9%
052.8 1 0.9% 17 3.0%
052.9 93 87.7% 461 82.6%
Total 296 100.0% 1658 100.0%
*ICD-9 code: 052.0 = postvaricella encephalitis, 052.1 = varicella (hemorrhagic) pneumonitis, 052.7 = varicella with other specified complications, 052.8 = varicella
with unspecified complication, 052.9 = varicella without complication.
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cella related. This also counts for 7 of the 8 deceased
patients that could not be included in the study. For
one deceased patient for whom both date and cause of
death were unknown, we cannot totally exclude the pos-
sibility that death was varicella related. However, this
patient was admitted because of moderate complications
(infected skin lesions and dehydration) that are unlikely
reasons for case fatality. At this moment we have there-
fore no reason to assume that the lower number of
admitted varicella patients in the Netherlands concerned
more severe or other presenting cases than in other
countries.
It is not easy to make a comparison of the severity of
varicella complications among hospitalized patients
between different countries. In a German study [9],
Table 4 Comparison of National Medical Register with
medical record research with regard to the attribution of
main or side diagnosis varicella
National Medical Register
Medical record research Main
diagnosis
Side
diagnosis
Total
Admission primary due to
varicella
180 (61%) 77 (26%) 257
Admission not primary due to
varicella
9 (3%) 29 (10%) 38
Total 189 106 295
Table 2 Reported underlying chronic conditions in
medical record research
Condition N %
No underlying chronic condition 176 60.7%
Underlying condition 114 39.3%
- Lung disorder 33
- Skin disorder 27
Eczema (18)
Constitutional eczema (7)
- Malignancy/leukemia 18
- Premature birth 13
- Immunosuppressive therapy 11
- Cardiovascular disease 6
- Primary or congenital immune disorder 4
- Thalassaemia 3
- Disorder of the thyroid gland 3
- Organ or bone marrow transplantation 2
- HIV 2
- Nephrotic syndrome 2
- Diabetes mellitus 2
- Liver disease 1
- Other chronic condition 27
Epilepsy (5)
Down syndrome (4)
Febrile convulsions (2)
Unknown 6 -
Total 296 100%
Table 3 Reported complications in medical record research
Complication N % Complication N %
Neurological Gastrointestinal tract
Cerebellitis, ataxia
2 9 3.0% Gastroenteritis
1 21 7.1%
Febrile convulsion
2 22 7.4% Stomatitis
1 13 4.4%
Convulsion without fever
2 1 0.3% (Imminent) dehydration
1 57 19.3%
Meningitis/encephalitis
2 7 2.4% Liver disorder
2 2 0.7%
Cerebral vasculitis/infart/bleeding
2 1 0.3% Secondary bacterial infections
Lower respiratory tract Sepsis
2 6 2.0%
Pneumonia
2 22 7.4% Osteomyelitis
2 1 0.3%
Bronchitis
1 or bronchiolitis
2 6 2.0% Bacterial arthritis
2 4 1.4%
Upper respiratory tract, ENT and eye Haematological/coagulation disorders
Otitis media
1 16 5.4% Thrombocytopenia
2 5 1.7%
Faryngitis/tonsillitis
1 10 3.4% Coagulation disorder
2 3 1.0%
Conjunctivitis
1 7 2.4% Leuco- and/or erythrocytopenia/anaemia
1 8 2.7%
Skin/subcutis Other complications
Bacterial super infections of skin lesions
1 82 27.7% Reactive arthritis
2 1 0.3%
Staphylococcal scalded skin syndrome
2 1 0.3% Other
1/2 15 5.1%
Erythema multiforme exsudativum
1 1 0.3%
Necrotizing fasciitis
2 1 0.3%
1 = relatively moderate complication,
2 = relatively severe complication.
van Lier et al. BMC Infectious Diseases 2011, 11:85
http://www.biomedcentral.com/1471-2334/11/85
Page 5 of 8where the incidence of varicella-related hospital admis-
sions was estimated to be approximately three times
higher than in the Netherlands (Germany 19.7 per
100,000 in children ≤16 years of age, the Netherlands
6.8 per 100,000 children ≤15 years of age), the propor-
tion of certain complications among hospitalized vari-
cella cases was rather comparable with the proportions
found in our study. In this German study they found a
febrile convulsion in 7.6% (Netherlands 8.7% in the
same age-group ≤16 years of age), meningo-encephalitis
in 5.7% (Netherlands 1.6%), cerebral vasculitis/infarct in
0.7% (Netherlands 0.4%), staphylococcal scalded skin
syndrome in 0.7% (Netherlands 0.4%), coagulation disor-
der in 5.6% (Netherlands 2.8%) and sepsis in 2.3%
Table 5 Comparison of National Medical Register (ICD-9 codes*) and medical record research with regard to registered
complications
Complications National Medical Register (LMR)
Medical record research 052.0
N
052.1
N
052.7
N
052.8
N
052.9
N
Total
N
Complication
registered N (%)
Neurological
Cerebellitis, ataxia 2 - 6 - 1 9 4 (44.4%)
Febrile convulsion - - 2 2 18 22 17 (77.3%)
Convulsion without fever ----1 1 1 (100.0%)
Meningitis/encephalitis - - 1 1 5 7 3 (42.9%)
Cerebral vasculitis/infart/bleeding - - 1 - - 1 1 (100.0%)
Lower respiratory tract
Pneumonia - 9 2 2 9 22 17 (77.3%)
Bronchitis or bronchiolitis - - 1 1 4 6
a 4 (66.7%)
Upper respiratory tract, ENT and eye
Otitis media - - 4 1 11 16 6 (37.5%)
Faryngitis/tonsillitis - - 1 - 9 10 5 (50.0%)
Conjunctivitis - - 3 - 4 7 1 (14.3%)
Skin/subcutis
Bacterial super infections of skin lesions - - 28 9 45 82
b 50 (61.0%)
Staphylococcal scalded skin syndrome ----1 1 1 (100.0%)
Erythema multiforme exsudativum ----1 1 0 (0.0%)
Necrotizing fasciitis - - - 1 - 1 0 (0.0%)
Gastrointestinal tract
Gastroenteritis - 2 5 1 13 21 12 (57.1%)
Stomatitis - - 2 1 10 13
c 9 (69.2%)
(Imminent) dehydration - - 8 4 45 57 26 (45.6%)
Liver disorder - 1 - 1 - 2 1 (50.0%)
Secondary bacterial infections
Sepsis - - 2 1 3 6 1 (16.7%)
Osteomyelitis - - 1 - - 1 1 (100.0%)
Bacterial arthritis - - 2 - 2 4 3 (75.0%)
Haematological/coagulation disorders
Thrombocytopenia - 1 - 1 3 5 1 (20.0%)
Coagulation disorder - - - 2 1 3 1 (33.3%)
Leuco- and/or erythrocytopenia/anaemia - 1 2 2 3 8 2 (25.0%)
Other complications
Reactive arthritis ----1 1 1 (100.0%)
Other - 1 4 - 10 15 10 (66.7%)
Total 2 11 51 17 215 296
*ICD-9 code: 052.0 = postvaricella encephalitis, 052.1 = varicella (hemorrhagic) pneumonitis, 052.7 = varicella with other specified complications, 052.8 = varicella
with unspecified complication, 052.9 = varicella without complication.
aacute upper respiratory infections registered in LMR were also included.
ball bacterial infections (also when it was not clear that it concerned the skin) registered in LMR were included.
cvolume depletion disorder and feeding difficulties and mismanagement, registered in LMR were also included (except for patients for whom (imminent)
dehydration was mentioned by the medical student as well).
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The reason behind the difference between both coun-
tries in the proportion of patients with meningo-ence-
phalitis and coagulation disorder to a lesser extent is
not clear. A possible explanation could be the difference
in median age of the study population (for Germany 3.3
years and for the Netherlands 1 year) because the sever-
ity of varicella complications is known to be related to
increasing age. Another possibility could be the differ-
ences in data collection methods between the German
study (nationwide, prospective, hospitals were asked
each month to send a reporting card to report all
patients with a varicella related condition, including
postinfectious varicella complications, and for these
patients additional information was collected) and the
Dutch study (not nationwide, retrospective, based on
available information in the medical record of patients).
A limitation of this study is that the selection of
patients was based on registration of varicella (as main
or side diagnosis) in the National Medical Register. In a
considerable part of patients, varicella was incorrectly
registered as side diagnosis instead of main diagnosis.
Furthermore, a considerable part of the patients were
incorrectly registered in the National Medical Register
as ‘varicella without complication’ or as ‘varicella with
unspecified complication’, sometimes despite the fact
that additional codes were registered in the National
Medical Register that were very likely complications
caused by varicella. We cannot exclude the possibility
that varicella might not have been registered at all in
another unknown number of patients. This means that
there is a chance of underestimation of the number of
hospitalizations due to varicella. Future research should
therefore focus on following up patients that consult
their GP due to varicella, to see how often they are
referred to a hospital.
Only a part of all Dutch hospitals participated in the
study, representative for 21.7% of all the admissions
with varicella in the Netherlands in 2003-2006, which
limits our study sample size. Furthermore, the records
of 3% of all patients with varicella diagnosis could not
be included due to lack of permission or missing
records in the hospital. However, the study population
was representative for all hospitalized patients with vari-
cella diagnosis in the Netherlands in 2003-2006, with
the exception of the type of hospital, but within the
study population both median duration of admission
and the proportion with at least one complication in the
academic hospital did not differ significantly from other
hospitals.
Conclusions
This study showed that a considerable part of the vari-
cella complications among hospitalized cases was rather
moderate and can normally be treated effectively,
although in a third of the hospitalized cases with com-
plications, severe complications occurred. Furthermore,
in spite of the lower incidence of hospital admissions
due to varicella, there is no reason to assume that the
severity of varicella among hospitalized patients in the
Netherlands differs from other countries. These data are
relevant in the decision-making process regarding
whether or not to introduce routine varicella vaccination
in the Netherlands.
Acknowledgements
We would like to thank the following persons and/or organizations:
- all hospitals and patients for their cooperation with the medical record
research
- Willem Hoogen Stoevenbeld of Prismant for providing data on hospital
admission (Dutch National Medical Register, LMR) and approaching the
hospitals for cooperation with the medical record research
- Suzan Schotman (RIVM) for her help with the comparison of complications
between the medical record research and the National Medical Register
- Sabine de Greeff (RIVM) for her help in the set-up of the medical record
research
Author details
1Department of Epidemiology and Surveillance, Centre for Infectious Disease
Control, National Institute for Public Health and the Environment (RIVM),
Postbox 1, 3720 BA Bilthoven, the Netherlands.
2Department of Pediatric
Immunology and Infectious diseases, University Medical Centre Utrecht
(UMCU), Postbox 85090, 3508 AB Utrecht, the Netherlands.
Authors’ contributions
AvL participated in the design and coordination of the study and drafted
the manuscript, NvdM and GR participated in the design and coordination
of the study and critically revised the manuscript, ES and HdM participated
in the design of the study and critically revised the manuscript. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 September 2010 Accepted: 5 April 2011
Published: 5 April 2011
References
1. Heininger U, Seward JF: Varicella. Lancet 2006, 368:1365-76.
2. Marin M, Meissner HC, Seward JF: Varicella prevention in the United
States: a review of successes and challenges. Pediatrics 2008, 122:e744-51.
3. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W,
Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, Weil-
Olivier C, Wutzler P: Varicella vaccination in Europe - taking the practical
approach. BMC Med 2009, 7:26.
4. VENICE: Report on First Survey of Immunisation Programs in Europe Rome:
VENICE; 2007 [http://venice.cineca.org/Report_II_WP3.pdf ].
5. de Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A,
Boot H: The epidemiology of varicella and herpes zoster in The
Netherlands: implications for varicella zoster virus vaccination. Vaccine
2006, 24:3946-52.
6. Fleming DM, Elliot AJ, Miles J, Barley MA, Grant S: Weekly Returns Service,
Annual Prevalence Report 2007 Birmingham: Royal College of General
Practitioners - Birmingham research unit; 2007 [http://www.rcgp.org.uk/pdf/
BRU%20Annual%20prevalence%20report%202007.pdf ].
7. Hospital Episode Statistics (HES) online: inpatient data, primary
diagnosis. [http://www.hesonline.nhs.uk].
8. Office for National Statistics: Mortality statistics (series DH2 no 27-32 and
series DR_06-DR_08) London: Office for National Statistics; 2000, http://www.
statistics.gov.uk/statbase/Product.asp?vlnk=618 and http://www.statistics.
gov.uk/statbase/Product.asp?vlnk=15096.
van Lier et al. BMC Infectious Diseases 2011, 11:85
http://www.biomedcentral.com/1471-2334/11/85
Page 7 of 89. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R: The
burden of varicella complications before the introduction of routine
varicella vaccination in Germany. Pediatr Infect Dis J 2008, 27:119-24.
10. Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I,
Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N,
Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragón MV,
Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E: The comparative
sero- epidemiology of varicella zoster virus in 11 countries in the
European region. Vaccine 2007, 25:7866-72.
11. Prismant: Dutch National Medical Register (LMR) Utrecht: Prismant; 2003.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/11/85/prepub
doi:10.1186/1471-2334-11-85
Cite this article as: van Lier et al.: Hospitalization due to varicella in the
Netherlands. BMC Infectious Diseases 2011 11:85.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
van Lier et al. BMC Infectious Diseases 2011, 11:85
http://www.biomedcentral.com/1471-2334/11/85
Page 8 of 8